Infections after living-donor liver transplantation

Area of Science:

• Hepatology
• Transplantation Surgery
• Infectious Disease Epidemiology

Background:

• The demand for organ transplants, particularly liver transplants, consistently exceeds the supply of cadaveric organs.
• Living-donor liver transplantation (LDLT) has emerged as a critical alternative to address organ shortages.
• Recent advancements have made LDLT outcomes comparable to deceased donor liver transplantation.

Purpose of the Study:

• To analyze the incidence and characteristics of infections in both living liver donors and recipients.
• To compare infection risks in LDLT recipients with those of cadaveric organ recipients.

Main Methods:

• A retrospective analysis of 40 living-donor liver transplantations performed between January 2002 and January 2006.
• Donors were typically first-degree relatives, assessed for excellent health and hepatic function.
• Data on infections in both donors and recipients were collected and analyzed.

Main Results:

• Three living donors experienced clinically relevant infections.
• Recipient infection rates and types were comparable to those of deceased donor liver transplant recipients.
• The most common infections included cholangitis (leading to septic shock in 5/14 infected patients) and intra-abdominal infections (leading to septic shock in 3/14 infected patients). Urinary tract infections (10) and pneumonia (3) were also observed.

Conclusions:

• Living-donor liver transplantation provides a crucial alternative for patients with end-stage liver disease, especially in regions with high waiting list mortality.
• LDLT can effectively mitigate the challenges posed by the scarcity of deceased donor organs.
• Careful management of potential infectious complications is essential for successful LDLT outcomes.